4//SEC Filing
AFEYAN NOUBAR 4
Accession 0000899243-22-025721
CIK 0001609809other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 5:00 PM ET
Size
19.2 KB
Accession
0000899243-22-025721
Insider Transaction Report
Form 4
Transactions
- Purchase
Common Stock
2022-07-05$3.15/sh+5,825,495$18,350,309→ 5,825,495 total(indirect: By Flagship Pioneering Fund VII, L.P.) - Purchase
Common Stock
2022-07-05$3.15/sh+2,912,748$9,175,156→ 5,875,711 total(indirect: By Nutritional Health LTP Fund, L.P.)
Holdings
- 1,283,282(indirect: By Flagship Ventures Fund IV-Rx, L.P.)
Common Stock
- 2,962,963(indirect: By Flagship Pioneering Fund VI, L.P.)
Common Stock
- 2,734,994(indirect: By LLC)
Common Stock
- 376,018(indirect: By Noubar B. Afeyan, Ph.D.)
Common Stock
- 4,434,600(indirect: By Flagship Ventures Fund IV, L.P.)
Common Stock
AFEYAN NOUBAR
Director10% Owner
Transactions
- Purchase
Common Stock
2022-07-05$3.15/sh+2,912,748$9,175,156→ 5,875,711 total(indirect: By Nutritional Health LTP Fund, L.P.) - Purchase
Common Stock
2022-07-05$3.15/sh+5,825,495$18,350,309→ 5,825,495 total(indirect: By Flagship Pioneering Fund VII, L.P.)
Holdings
- 2,734,994(indirect: By LLC)
Common Stock
- 2,962,963(indirect: By Flagship Pioneering Fund VI, L.P.)
Common Stock
- 376,018(indirect: By Noubar B. Afeyan, Ph.D.)
Common Stock
- 4,434,600(indirect: By Flagship Ventures Fund IV, L.P.)
Common Stock
- 1,283,282(indirect: By Flagship Ventures Fund IV-Rx, L.P.)
Common Stock
Nutritional Health LTP Fund, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2022-07-05$3.15/sh+2,912,748$9,175,156→ 5,875,711 total(indirect: By Nutritional Health LTP Fund, L.P.) - Purchase
Common Stock
2022-07-05$3.15/sh+5,825,495$18,350,309→ 5,825,495 total(indirect: By Flagship Pioneering Fund VII, L.P.)
Holdings
- 1,283,282(indirect: By Flagship Ventures Fund IV-Rx, L.P.)
Common Stock
- 2,734,994(indirect: By LLC)
Common Stock
- 4,434,600(indirect: By Flagship Ventures Fund IV, L.P.)
Common Stock
- 2,962,963(indirect: By Flagship Pioneering Fund VI, L.P.)
Common Stock
- 376,018(indirect: By Noubar B. Afeyan, Ph.D.)
Common Stock
Flagship Pioneering, LLC
10% Owner
Transactions
- Purchase
Common Stock
2022-07-05$3.15/sh+2,912,748$9,175,156→ 5,875,711 total(indirect: By Nutritional Health LTP Fund, L.P.) - Purchase
Common Stock
2022-07-05$3.15/sh+5,825,495$18,350,309→ 5,825,495 total(indirect: By Flagship Pioneering Fund VII, L.P.)
Holdings
- 4,434,600(indirect: By Flagship Ventures Fund IV, L.P.)
Common Stock
- 1,283,282(indirect: By Flagship Ventures Fund IV-Rx, L.P.)
Common Stock
- 2,962,963(indirect: By Flagship Pioneering Fund VI, L.P.)
Common Stock
- 2,734,994(indirect: By LLC)
Common Stock
- 376,018(indirect: By Noubar B. Afeyan, Ph.D.)
Common Stock
Footnotes (8)
- [F1]On July 5, 2022, Nutritional Health LTP Fund, L.P. ("Nutritional LTP") and Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") acquired 2,912,748 shares and 5,825,495 shares, respectively, of the Issuer's Common Stock in a registered direct offering at a price of $3.15 per share.
- [F2]Shares held by Nutritional LTP. Nutritional Health LTP Fund General Partner LLC ("Nutritional LTP GP") is the general partner of Nutritional LTP. Noubar B. Afeyan, Ph.D. ("Dr. Afeyan") is the sole member and manager of Nutritional LTP GP. Each of the reporting persons except for Nutritional LTP disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
- [F3]Shares held by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Flagship Fund VII GP. Dr. Afeyan is the Chief Executive Officer, sole shareholder and director of Flagship Pioneering. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
- [F4]Shares held by Flagship Ventures Fund IV, L.P. ("Flagship Fund IV"). Flagship Ventures Fund IV General Partner LLC ("Flagship Fund IV GP") is the general partner of Flagship Fund IV. Dr. Afeyan is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
- [F5]Shares held by Flagship Ventures Fund IV-Rx, L.P. ("Flagship Fund IV-Rx"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. Dr. Afeyan is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
- [F6]Shares held by Flagship Pioneering Fund VI, L.P. ("Flagship Fund VI"). Flagship Pioneering Fund VI General Partner LLC ("Flagship Fund VI GP") is the general partner of Flagship Fund VI. Flagship Pioneering is the manager of Flagship Fund VI GP. Dr. Afeyan is the CEO, sole shareholder and director of Flagship Pioneering. Each of the reporting persons except Flagship Fund VI disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
- [F7]Shares held by Flagship VentureLabs IV LLC ("VentureLabs IV"). Flagship Fund IV is a member of VentureLabs IV and also serves as its manager. Each of the reporting persons except VentureLabs IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
- [F8]Shares held by Dr. Afeyan. Each of the reporting persons except for Dr. Afeyan disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. Includes 12,853 shares held through a trust for the benefit of Dr. Afeyan's children. Dr. Afeyan disclaims Section 16 beneficial ownership of these shares except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares for Section 16 or any other purpose.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001222012
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 5:00 PM ET
- Size
- 19.2 KB